ACOR - Acorda Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

with an average price target of $173.85. This is a potential upside of $172.65 (14387.5%) from yesterday's end of day stock price of $1.2.

Acorda Therapeutics's activity chart (see below) currently has 40 price targets and 27 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 61.43% with an average time for these price targets to be met of 87.57 days.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 17-Jun-2021. First documented stock forecast 24-Sep-2014.

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

200

$198.8 (16566.67%)

3960

2 years 9 months 27 days ago

0/4 (0%)

$103 (106.19%)

Buy

100

$98.8 (8233.33%)

3600

3 years 3 months ago

2/4 (50%)

$-22.4 (-18.30%)

139

Hold

120

$118.8 (9900.00%)

2280

3 years 11 months 7 days ago

5/5 (100%)

$16.79 (16.27%)

44

Hold

120

$118.8 (9900.00%)

3000

3 years 11 months 7 days ago

6/6 (100%)

$16.79 (16.27%)

45

Sell

120

$118.8 (9900.00%)

1200

4 years 5 months 23 days ago

7/7 (100%)

$-165.6 (-57.98%)

161

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ACOR (Acorda Therapeutics) average time for price targets to be met?

On average it took 87.57 days on average for the stock forecasts to be realized with a an average price target met ratio 61.43

Which analyst has the current highest performing score on ACOR (Acorda Therapeutics) with a proven track record?

THOMAS SHRADER

Which analyst has the current lower performing score on ACOR (Acorda Therapeutics) with a proven track record?

RAGHURAM SELVARAJU

Which analyst has the most public recommendations on ACOR (Acorda Therapeutics)?

Thomas Shrader works at BTIG and has 10 price targets and 8 ratings on ACOR

Which analyst is the currently most bullish on ACOR (Acorda Therapeutics)?

Thomas Shrader with highest potential upside - $1785.51

Which analyst is the currently most reserved on ACOR (Acorda Therapeutics)?

Charles Duncan with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?